Prise en charge des hypertriglycéridémies et du risque de pancréatite [The management of hypertriglyceridemia and the risk of pancreatitis]

Détails

Ressource 1Télécharger: RMS_790-2_1464.pdf (818.89 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_D23403F835DB
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Prise en charge des hypertriglycéridémies et du risque de pancréatite [The management of hypertriglyceridemia and the risk of pancreatitis]
Périodique
Revue medicale suisse
Auteur⸱e⸱s
Garelli V., Pauchet A., Kissling S., Sartori C., Rodondi N., Collet T.H.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
04/03/2020
Peer-reviewed
Oui
Volume
16
Numéro
684
Pages
451-454
Langue
français
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Résumé
In the face of hypertriglyceridemia, the potential causes must be assessed to choose the best medical therapeutic option. In cases of secondary hypertriglyceridemia, physicians should use treatments targeting the pathophysiological mechanisms underlying the lipid disorder. Lifestyle interventions are the cornerstone of an effective treatment, to achieve controlled glycemia, blood pressure and weight loss. Only in cases where these measures are insufficient, fibrates can be trialed although their clinical benefit is controversial, with special caution when combined with statins (risk of rhabdomyolysis). Plasmapheresis or intravenous insulin therapy are only used in severe situations after a multidisciplinary decision process in the hospital setting. The clinical case presented here reminds us to assess hypertriglyceridemia in the face of any acute pancreatitis.
Mots-clé
Acute Disease, Humans, Hypertriglyceridemia/complications, Hypertriglyceridemia/therapy, Insulin/administration & dosage, Insulin/therapeutic use, Pancreatitis/complications, Plasmapheresis
Pubmed
Création de la notice
17/06/2020 10:24
Dernière modification de la notice
20/08/2022 7:14
Données d'usage